Novo Nordisk Q3 Adj. EPS $0.87 Beats $0.81 Estimate, Sales $11.900B Beat $11.390B Estimate
Benzinga Newsdesk 9 hours ago
NewsEarningsHotEarnings Beats
Novo Nordisk (NYSE:NVO) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.81 by 7.41 percent. This is a 15.53 percent decrease over earnings of $1.03 per share from the same
Novo Nordisk (NYSE:NVO) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.81 by 7.41 percent. This is a 15.53 percent decrease over earnings of $1.03 per share from the same period last year. The company reported quarterly sales of $11.900 billion which beat the analyst consensus estimate of $11.390 billion by 4.48 percent. This is a 1.32 percent increase over sales of $11.745 billion the same period last year.